Cabazitaxel in Platinum Refractory Ovarian Cancer

This study is currently recruiting participants.
Verified March 2014 by Vejle Hospital
Sponsor:
Collaborator:
Sanofi
Information provided by (Responsible Party):
Vejle Hospital
ClinicalTrials.gov Identifier:
NCT01747239
First received: December 6, 2012
Last updated: March 28, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2015
  Estimated Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)